Table 1 Demographic and biochemical characteristics of the individuals at enrollment.

From: Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome

 

Without MS

With MS

P

n

80

60

 

Sex, M/F

40/40

34/26

0.495

Age, y

58.8 ± 12.2

61.1 ± 9.0

0.221

Weight, kg

75 ± 16

93 ± 13

<0.001

BMI, kg/m2

27.4 ± 5.5

33.8 ± 4.4

<0.001

Body adiposity, %

34.6 ± 7.5

41.0 ± 7.3

<0.001

Waist circumference, cm

92 ± 14

109 ± 9

<0.001

SBP, mm Hg

136 ± 24

143 ± 18

0.053

DBP, mm Hg

80 ± 12

84 ± 10

0.029

Glucose, mg/dL

94 ± 13

114 ± 19

<0.001

Insulin, μU/mL

4.2 ± 3.3

13.6 ± 10.2

<0.001

HOMA

1.0 ± 0.8

3.9 ± 3.3

<0.001

QUICKI

0.408 ± 0.053

0.327 ± 0.035

<0.001

Triglycerides, mg/dL

88 ± 33

154 ± 90

<0.001

Cholesterol, mg/dL

215 ± 35

209 ± 48

0.331

LDL-C, mg/dL

135 ± 35

126 ± 37

0.148

HDL-C, mg/dL

63 ± 17

50 ± 14

<0.001

Uric acid, mg/dL

5.2 ± 1.5

6.2 ± 1.3

<0.001

WBC, 106 cells/mL

6.2 ± 1.8

7.1 ± 1.6

0.007

ALT, IU/L

14 ± 4

18 ± 9

<0.001

AST, IU/L

14 ± 17

23 ± 15

0.009

AST/ALT ratio

1.06 ± 0.52

0.76 ± 0.29

<0.001

γ-GT, IU/L

18 ± 11

41 ± 38

<0.001

Creatinine, mg/dL

0.92 ± 0.17

0.90 ± 0.26

0.553

  1. Data presented as mean ± SD. Individuals were matched by age and sex. MS, metabolic syndrome; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA, homeostatic model assessment; QUICKI, quantitative insulin sensitivity check index; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; WBC, white blood cells; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GT, γ-glutamyltransferase. Differences between groups were analyzed by two-tailed unpaired Student’s t tests. Differences in gender distribution were analyzed by χ2 analysis.
Back to article page